UBS revises Coloplast rating to ‘neutral,’sees lower risk
UBS has adjusted its rating on Coloplast (CSE:COLOb) A/S, upgrading the Danish healthcare company to “neutral” from “sell.” This revision reflects changes in
UBS has adjusted its rating on Coloplast (CSE:COLOb) A/S, upgrading the Danish healthcare company to “neutral” from “sell.” This revision reflects changes in
(Reuters) – Albertsons (NYSE:ACI) on Wednesday terminated its $25 billion merger agreement with Kroger (NYSE:KR) after the U.S. District Court in Oregon
(Reuters) -Macy’s on Wednesday cut its annual profit forecast, sending shares down 10% as weak demand at its nameplate stores clouds its
On Wednesday, Reuters reported that China’s leadership is contemplating a strategy to allow the yuan to weaken in the year 2025. This
By Aishwarya Jain (Reuters) – U.S. hotels and travel companies are aiming to tap a surge in Indian tourists to boost revenue as
Investing.com — U.S. airline stocks are set to propel in 2025, with tailwinds like robust demand, disciplined capacity growth, and favourable fuel prices
Investing.com – US stock index futures edged higher Wednesday, with sentiment helped by in line consumer inflation data largely cementing a Federal
(Reuters) – A U.S. government panel is set to submit its recommendations this month on whether a Japanese takeover of U.S. Steel
By Echo Wang NEW YORK (Reuters) – AlpInvest Partners, the secondary investments unit of buyout firm Carlyle Group (NASDAQ:CG), and Abu
LONDON (Reuters) – Another human pandemic could cause economic losses of $13.6 trillion for the global economy over a five-year period, commercial